# B Positive National Blood Services – FDA 483, Jul 24, 2026

Source: https://www.keypedia.com/records/483/b-positive-national-blood-services/a1a036a7-3d5d-43ab-9680-0e3692f1cf0f

> FDA 483 for B Positive National Blood Services on July 24, 2026. Product: biologics. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: B Positive National Blood Services
- Inspection Date: 2026-07-24
- Product Type: biologics
- Office Name: Philadelphia District Office
- Summary: An FDA inspection of B Positive National Blood Services - Holmes, LLC, a Plasmapheresis Center, revealed significant deficiencies in donor notification procedures and equipment maintenance documentation. The firm failed to inform donors of all test results and deferral statuses in a timely manner. Additionally, critical quality control, cleaning, and maintenance activities for freezers used in blood component storage were not properly documented.

## Related Officers

- [Kish Bolden](https://www.keypedia.com/people/kish-bolden/e24957d4-927f-40c7-a7ca-860fedce2e3f)

Company: https://www.keypedia.com/companies/b-positive-national-blood-services/a70f7a6b-76e7-4c85-937d-2e1f8bec7415

Office: https://www.keypedia.com/offices/philadelphia-district-office/c5ec7398-b3d5-4125-9793-fb7b972578d8